Health TrialsbyHealthPanel

Protocol Study on Addiction, Trauma and Immigration Among Vulnerable Young Adults in Grand Est

ConditionsTrauma and Stress-related DisordersSubstance Use Disorder (SUD)Substance Use Risk
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-25
SponsorUniversity of Lorraine

About this trial

The ATICC study (Addiction, Trauma, and Immigration, Prevention and Cross-Cultural Support for Care) investigates the complex relationships between trauma, substance use, migration experiences, and mental health perceptions among vulnerable young adults in Transitional Housing (Foyers de Jeunes Travailleurs) in France. Using a tripartite methodology, the study includes: (1) a cross-sectional survey to identify risk factors, (2) qualitative interviews to explore individual experiences, and (3) a longitudinal intervention using focus groups to assess psychological well-being and attitudes toward care. The findings will contribute to developing culturally adapted prevention and support programs.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Resident in a Housing center, speak and read french, adult participants who are not under guardianship or curatorship, any cultural background.

Disqualifiers

minors, don't speak and read french, adults under guardianship and curatorship.

Trial population

The study population consists of young adults aged 16 to 25 years residing in Transitional Housing for Young Adults (Foyers de Jeunes Travailleurs, FJT) affiliated with the Union Régionale pour l'Habitat des Jeunes (URHAJ). These individuals meet specific vulnerability criteria and come from diverse life trajectories, including those aging out of child welfare services (ASE), individuals under judicial protection (PJJ), persons with disabilities, refugees, and single-parent families. Due to their backgrounds, these young adults face significant adversity, which may have profound effects on their mental health and well-being. This population is particularly exposed to psychosocial stressors, making them a relevant demographic for studying the interplay between trauma, substance use, and mental health care access.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Focus group

    Other intervention

    The "Well-Being Coffee Group" intervention is implemented in two formats: in person and others via videoconference, all facilitated by the same psychologist throughout the study. Across all formats, participation is voluntary and follows an information phase and the signing of an informed consent form. Participants will complete standardized evaluation questionnaires at multiple time points. The discussion groups are designed to create a supportive and open environment that encourages free expression. Their goal is to provide participants with a space to share their thoughts, emotions, and personal experiences, as well as to reflect on those emerging from group discussions. Topics explored include identity, substance use, migratory experiences, and mental health, fostering meaningful dialogue and mutual support.

Treatment groups

182 Participants
are divided into 1 treatment group
Group A: group participants1 intervention

Trial outcomes

Primary outcomes

1

Attitudes toward mental health care

Attitudes toward mental health care is measured through changes in perceptions of mental health services, stigma, and willingness to seek care before and after the intervention through a validated scale.

Time frame
6 months

Secondary outcomes

1

Anxiety

Anxiety is a mental health condition characterized by excessive worry, fear, or nervousness that can interfere with daily functioning. Generalized Anxiety Disorder (GAD) is one of the most common forms assessed using the GAD-7, a self-report screening measure developed to address limitations in existing anxiety assessments. The GAD-7, consisting of seven questions, is widely used in adult primary care and psychiatric settings due to its efficiency, reliability, and sensitivity to treatment-related changes.

Time frame
6 months
2

Depression

Depression is a mood disorder characterized by persistent sadness, loss of interest or pleasure in activities, and other symptoms that interfere with daily life. It can vary in severity and last for weeks, months, or even years. Depression in this study will be assessed using the PHQ-9, a screening tool used to assess the presence and severity of depression. It is based on the nine diagnostic criteria for major depressive disorder from the DSM-IV. Each question in the PHQ-9 assesses a specific symptom of depression and is rated on a scale from 0 to 3, depending on how often the symptom has been experienced in the last two weeks.

Time frame
6 months
3

Alcohol use

Alcohol use will be assessed using the Alcohol Use Disorders Identification Test (AUDIT) to identify individuals with risky or harmful alcohol consumption and detect alcohol dependence. The AUDIT questionnaire consists of 10 questions, divided into three categories, alcohol consumption, alcohol-Related problems and signs of alcohol dependence.

Time frame
6 months
4

Tobacco use

Nicotine dependence is going to be assessed the Fagerström test for nicotine dependence that measures the level of nicotine addiction in individuals who smoke cigarettes. Each question is designed to evaluate the degree of nicotine dependence based on smoking behaviors.

Time frame
6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Lorraine

Lead sponsor

French Institute for Public Health Research (IReSP)

Collaborator

Source ClinicalTrials.gov
Apply now